BRIEF published on 08/03/2026 at 15:20, 1 month 8 days ago The Vanguard Group's Interest in Rotork plc Disclosed Financial Transactions Takeover Code Securities Disclosure Vanguard Group Rotork Plc
PRESS RELEASE published on 08/03/2026 at 15:20, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses a 4.75% ownership in Tate & Lyle plc through Form 8.3 on 31 July 2026 Form 8.3 The Vanguard Group Ownership Disclosure Financial Securities Tate & Lyle Plc
BRIEF published on 08/03/2026 at 15:19, 1 month 8 days ago The Vanguard Group's Disclosure on Prologis, Inc. Takeover Code Vanguard Group Securities Transactions SEC Disclosure Prologis Inc
PRESS RELEASE published on 08/03/2026 at 15:19, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.55% interest in Spire Healthcare Group plc with 14,288,265 shares. Dealings include purchases and sales of 1p ordinary shares at 2.34 GBP per unit Shares Disclosure Vanguard Group Spire Healthcare Dealings
BRIEF published on 08/03/2026 at 15:19, 1 month 8 days ago The Vanguard Group, Inc. Discloses Position in Picton Property Income Limited Disclosure Takeover Code Vanguard Group Picton Property Income Securities Interest
PRESS RELEASE published on 08/03/2026 at 15:17, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.65% stake in SEGRO plc. Additional disclosure for Prologis, Inc. Position disclosed on 31 July 2026 Disclosure Vanguard Group Stake SEGRO PLC Prologis Inc.
BRIEF published on 08/03/2026 at 15:17, 1 month 8 days ago Vanguard Discloses Position in LondonMetric and Schroder Real Estate Securities Form 8.3 Vanguard LondonMetric Schroder Real Estate
PRESS RELEASE published on 08/03/2026 at 15:16, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.71% interest in Schroders plc as of 31 July 2026. Details of securities transactions included The Vanguard Group Schroders Plc Securities Transactions Interest Disclosure 31 July 2026
BRIEF published on 08/03/2026 at 15:16, 1 month 8 days ago The Vanguard Group Discloses Position in JTC plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure JTC Plc
PRESS RELEASE published on 08/03/2026 at 15:15, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses 5.44% stake in Rotork plc as per Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure Rotork Plc
Published on 09/12/2026 at 02:35, 1 hour 41 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 5 hours 16 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 6 hours 11 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 6 hours 51 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 11 hours 16 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 6 hours 1 minute ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 6 hours 6 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 8 hours 31 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 10 hours 1 minute ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 21 hours 16 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 21 hours 16 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 8 hours ago Availability of the 2026 Interim Financial Report
